Bioceltix SAGPW: BCX

Bioceltix Signs Advisory Agreement For FDA Regulatory Support

· Issued by Bioceltix SA

On 6ix: 6ix.com/news/bioceltix-signs-advisory-agreement-for-fda-regulatory-support

Bioceltix S.A. GPW:BCX:

  • SAID ON MONDAY THAT IT HAD SIGNED AN ADVISORY AGREEMENT FOR REGULATORY SUPPORT OF VETERINARY STEM CELL PRODUCTS IN US MARKET

  • PARTNER TO ASSIST IN DIALOGUE WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND CENTER FOR VETERINARY MEDICINE (CVM)

  • AGREEMENT SIGNED FOR PERIOD OF UP TO 3 YEARS

  • ESTIMATES ABOUT 6 TO 9 MONTHS TO REACH FIRST MEETING WITH FDA/CVM

  • POTENTIAL ADMINISTRATIVE FEE TOTALS $165,441 IF FEE WAIVER IS NOT GRANTED

Source text:

Further company coverage:

Bioceltix SA on 6ix

Earlier from Bioceltix

Later from Bioceltix

All Bioceltix news releases